Clinical Trial Update: RA-4: 13-cis Retinoic Acid for Treatment of Men With Azoospermia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 13-cis retinoic acid (RA-4) for treatment of azoospermia in men has completed and results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Azoospermia
• Male Infertility

Drugs mentioned

• 13-cis-retinoic acid (13-cis-retinoic acid)

Snippet

Sponsor: University of Washington | Conditions: Male Infertility, Azoospermia | Phase 2 | Status: COMPLETED | Results posted: 2021-10-26